Celldex Therapeutics (CLDX)
(Delayed Data from NSDQ)
$36.30 USD
+0.04 (0.11%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $35.45 -0.85 (-2.34%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.67 |
EPS Last Quarter | -0.57 |
Last EPS Surprise | 25.00% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.85 |
Next Year | -3.36 |
EPS (TTM) | -2.65 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.30M | 1.44M | 5.85M | 5.95M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 1.60M | 1.60M | 6.50M | 6.50M |
Low Estimate | 1.00M | 1.28M | 5.20M | 5.40M |
Year ago Sales | 0.97M | 0.27M | 6.88M | 5.85M |
Year over Year Growth Est. | 34.02% | 433.33% | -15.02% | 1.71% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.67 | -0.68 | -2.85 | -3.36 |
# of Estimates | 4 | 3 | 5 | 4 |
Most Recent Consensus | -0.67 | -0.69 | -2.84 | -3.17 |
High Estimate | -0.64 | -0.67 | -2.81 | -3.17 |
Low Estimate | -0.69 | -0.69 | -2.90 | -3.52 |
Year ago EPS | -0.62 | -0.65 | -2.66 | -2.85 |
Year over Year Growth Est. | -8.06% | -4.62% | -7.14% | -18.05% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.67 | -0.68 | -2.85 | -3.36 |
7 Days Ago | -0.67 | -0.68 | -2.85 | -3.36 |
30 Days Ago | -0.67 | -0.68 | -2.93 | -3.36 |
60 Days Ago | -0.71 | -0.72 | -3.31 | -4.02 |
90 Days Ago | NA | NA | -3.30 | -4.10 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.68 | -2.84 | -3.36 |
Zacks Consensus Estimate | -0.67 | -0.68 | -2.85 | -3.36 |
Earnings ESP | 0.00% | 0.00% | 0.28% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.57 | -0.81 | -0.65 | -0.62 | NA |
Estimate | -0.76 | -0.67 | -0.65 | -0.63 | NA |
Difference | 0.19 | -0.14 | 0.00 | 0.01 | 0.02 |
Surprise | 25.00% | -20.90% | 0.00% | 1.59% | 1.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more